Trademarkia Logo

Australia

AU$
FLUVIXVY
Accepted: In opposition period

Last updated on 22 May 2025

Owner Info

GlaxoSmithKline Biologicals S.A.

Rue de l'Institut 89

B-1330 Rixensart, BELGIUM

Serial Number

2542453 filed on 17 Feb 2025

Correspondent

Legal Brand Protection Legal and Compliance GSK

79 New Oxford Street,

London WC1A 1DG,

UNITED KINGDOM

FLUVIXVY

Classification Information


Class [005]
Pharmaceutical and medicinal preparations and substances; vaccines.

Mark Details


Serial Number

2542453

Registered On

NA

Renewal On

NA

Mark Type

WORD

Priority Claim (Convention Details)


Date

20 Nov 2024

Mark Type

BX

Legal History


Show more

Status DateAction Taken
22nd May 2025Amendment to International Registration Contact Requested
10th May 2025Application Accepted correspondence sent
9th May 2025IP Right has been Examined
9th May 2025IP Right Acceptance Published
9th May 2025Status change to Accepted
1st May 2025Amendment to International Registration Contact Requested
30th Apr 2025Awaiting examination
30th Apr 2025Examination expedited
24th Apr 2025IP Right Filed Published
24th Apr 2025Status change to Published